🇺🇸 Acarizax in United States

379 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Off Label Use — 108 reports (28.5%)
  2. Dyspnoea — 52 reports (13.72%)
  3. Product Administered To Patient Of Inappropriate Age — 49 reports (12.93%)
  4. Product Use Issue — 28 reports (7.39%)
  5. Dysphagia — 27 reports (7.12%)
  6. Mouth Swelling — 26 reports (6.86%)
  7. Nausea — 25 reports (6.6%)
  8. Throat Irritation — 23 reports (6.07%)
  9. Lip Swelling — 21 reports (5.54%)
  10. Drug Administered To Patient Of Inappropriate Age — 20 reports (5.28%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Acarizax approved in United States?

Acarizax does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Acarizax in United States?

University Hospital, Montpellier is the originator. The local marketing authorisation holder may differ — check the official source linked above.